Mumbai, February 28, 2019: Sanofi Genzyme, the specialty care global business unit of Sanofi, observes Rare Disease Day on 28th February 2019, in India. Rare Disease Day takes place on the last day of February, a month known for having a ‘rare’ number of days. Sanofi Genzyme has partnered with – Organization of Rare Diseases India (ORDI) for the ‘RaceFor7’ run in Mumbai, Bengaluru, Chennai and New Delhi; and with Lysosomal Storage Disorders Support Society (LSDSS) to raise awareness in Delhi, Chennai, Jaipur and Kozhikode about such debilitating disorders.
Given the nature of rare diseases, there is limited awareness of the concept, the existence, the diagnosis and the prevalence of such diseases. This day provides an important opportunity to shed light on the impact that these chronic and debilitating diseases have on patients and their families. Sanofi Genzyme is committed to working with the medical fraternity, the government, scientific bodies, universities and patient advocacy groups to support greater awareness & education for timely diagnosis and access to treatment.
Sanofi Genzyme’s humanitarian program is in its 21st year in India and supports over 130 patients diagnosed with four of the treatable Lysosomal Storage Disorders. Through India Charitable Access Program, it provides the treatment totally free of cost to these patients, in a country where treatment access is limited.
Sanofi Genzyme in India is focused on treatment for rare diseases, multiple sclerosis and immunology, and is committed to working with key stakeholders to develop sustainable partnership models.
Corporate Comm India(CCI NewsWire)
